131
Participants
Start Date
September 25, 2020
Primary Completion Date
October 1, 2028
Study Completion Date
October 1, 2033
Eflornithine
DFMO (difluoromethylornithine) will be given at a dose of 1000 mg/m2 BID on each day of study.
RECRUITING
Penn State Milton S. Hershey Medical Center and Children's Hospital, Hershey
RECRUITING
Children's Hospital of The King's Daughters, Norfolk
RECRUITING
Levine Children's Hospital, Charlotte
NOT_YET_RECRUITING
Medical University of South Carolina, Charleston
RECRUITING
Augusta University Health, Augusta
RECRUITING
Arnold Palmer Hospital for Children, Orlando
RECRUITING
St. Joseph's Children's Hospital, Tampa
RECRUITING
University of Alabama, Children's Alabama, Birmingham
RECRUITING
University of Louisville, Louisville
RECRUITING
Cleveland Clinic Children's, Cleveland
RECRUITING
Helen DeVos Children's Hospital, Grand Rapids
RECRUITING
Medical College of Wisconsin, Milwaukee
RECRUITING
Children's Hospital and Clinics of Minnesota, Minneapolis
RECRUITING
Cardinal Glennon Children's Hospital, St Louis
RECRUITING
Children's Mercy Hospitals and Clinics, Kansas City
RECRUITING
Arkansas Children's Hospital, Little Rock
RECRUITING
Children's Medical Center Dallas, Dallas
RECRUITING
Dell Children's Blood and Cancer Center, Austin
RECRUITING
Rady Children's Hospital, San Diego
RECRUITING
UCSF Benioff Children's Hospital Oakland-, Oakland
RECRUITING
Kapiolani Medical Center for Women and Children, Honolulu
RECRUITING
Connecticut Children's Hospital, Hartford
RECRUITING
Hackensack University Medical Center, Hackensack
RECRUITING
Hasbro Children's Hospital, Providence
RECRUITING
CancerCare Manitoba, Winnipeg
RECRUITING
UHC Sainte-Justine, Montreal
RECRUITING
CHUQ, Québec
RECRUITING
CIUSSS de l'Estrie-CHUS, Sherbrooke
RECRUITING
Montreal Children's Hospital, Montreal
Collaborators (1)
K C Pharmaceuticals Inc.
INDUSTRY
Beat NB Cancer Foundation
OTHER
Team Parker for Life
UNKNOWN
USWM, LLC
UNKNOWN
Giselle Sholler
OTHER